GUARINI, PATRICK ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 103
EU - Europa 40
AS - Asia 23
Totale 166
Nazione #
US - Stati Uniti d'America 103
SE - Svezia 19
CN - Cina 15
IT - Italia 11
FR - Francia 6
SG - Singapore 4
IN - India 3
DE - Germania 1
ES - Italia 1
GB - Regno Unito 1
IE - Irlanda 1
IL - Israele 1
Totale 166
Città #
Nyköping 19
Chandler 18
Fairfield 11
Bari 6
Lawrence 6
Ashburn 5
Paris 5
Shanghai 5
Boardman 4
Cambridge 4
Des Moines 4
Roxbury 4
Inglewood 3
Pune 3
Seattle 3
Guangzhou 2
Houston 2
Marsala 2
New York 2
Princeton 2
Sant'Andrea Bagni 2
Singapore 2
West Jordan 2
Ann Arbor 1
Beijing 1
Córdoba 1
Dublin 1
Heze 1
Jerusalem 1
Jiaxing 1
New Bedfont 1
Nuremberg 1
San Diego 1
Strasbourg 1
Woodbridge 1
Totale 128
Nome #
DARA-VD VERSUS DARA-RD AS SALVAGE THERAPY FOR PATIENTS WITH MYELOMA. INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY RETE EMATOLOGICA PUGLIESE 40
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine—Results from the Italian ‘Back to Life’ project 37
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP) 36
Late Endocrine and Metabolic Sequelae and Long‐Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B‐Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi 31
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives 23
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 21
Totale 188
Categoria #
all - tutte 1.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 16 0 0 0 0 2 0 0
2021/202247 5 7 0 1 0 2 6 1 6 3 8 8
2022/202360 8 12 3 2 2 8 5 7 11 0 1 1
2023/202446 9 8 3 3 1 9 1 0 0 4 1 7
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 188